Fundraising Fox

Livongo

Mountain View, US · Delaware corporation · 80 employees on LinkedIn · 11 known investors

Livongo offers a chronic condition management program combining connected health-monitoring devices (blood glucose meters, blood pressure monitors, scales), certified health coaches, and clinical support to help members manage diabetes, hypertension, and weight, including GLP-1 medication access. It is delivered to members through their employer or health plan at no direct cost to the patient.

Also known as Livongo by Teladoc Health · Livongo Health

Founders & leadership

JE
JOSEPH E. CAREYExecutive
BV
BRIAN VANDENBERGExecutive
MC
MARIO CHRISTOPHERExecutive

Board

BSBETH SEIDENBERG
BETH SEIDENBERGin𝕏Board Director (Kleiner Perkins)until 2020Founding Managing Director at Westlake Village BioPartners
LSLEE SHAPIRO
LEE SHAPIROinChief Financial Officer2013–2020Partner at 7wire Ventures
HTHEMANT TANEJA
HEMANT TANEJAin𝕏Board director2014–2020CEO & Managing Director of General Catalyst
NBNIKO BONATSOS
NIKO BONATSOSin𝕏Board Director (General Catalyst)until 2020Founder and Managing Partner of Verdict
GT
GLEN TULLMANFounder and Executive Chairman2014–2020
TM
TOM MAINBoard directoruntil 2020

Investors · 11

Reported raises · per SEC filings

Form D private placements

$227M disclosed across 4 rounds · 2015–2018

$105MraisedApr 2018 · 15 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Phillip D. GreenDirector
  • Lee ShapiroDirector
  • Christopher BischoffDirector
  • Lynne Chou O'KeefeDirector
  • Jennifer SchneiderExecutive Officer
  • Hemant TanejaDirector
  • Glen TullmanExecutive Officer, Director
  • Andrew PageExecutive Officer
  • William J. TarantoDirector
  • Joe CareyExecutive Officer
  • Erica PalsisExecutive Officer
  • Dave EngbergExecutive Officer
Offering amount
$105M
Amount sold
$105M
First sale
Apr 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$52.5MraisedMar 2017 · 17 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Glen TullmanExecutive Officer
  • Phil GreenDirector
  • Anna BairdExecutive Officer
  • Lee ShapiroDirector
  • Hemant TanejaDirector
  • William J TarantoDirector
  • Lynne Chou O'KeefeDirector
Offering amount
$52.5M
Amount sold
$52.5M
First sale
Mar 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$49.5MraisedApr 2016 · 12 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Tom MainDirector
  • Glen TullmanExecutive Officer, Director
  • Lee ShapiroDirector
  • Anna BairdExecutive Officer
  • William J. TarantoDirector
  • Brian VandenbergExecutive Officer
  • Hemant TanejaDirector
Offering amount
$49.5M
Amount sold
$49.5M
First sale
Apr 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$20MraisedApr 2015 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • JOSEPH E. CAREYExecutive Officer
  • BETH SEIDENBERGDirector
  • LEE SHAPIRODirector
  • TOM MAINDirector
  • BRIAN VANDENBERGExecutive Officer
  • HEMANT TANEJADirector
  • NIKO BONATSOSDirector
  • MARIO CHRISTOPHERExecutive Officer
  • GLEN TULLMANExecutive Officer, Director
Offering amount
$20M
Amount sold
$20M
First sale
Mar 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Company profile

researched Aug 2026

Livongo, branded as "Livongo by Teladoc Health," delivers digital chronic condition management programs to individuals who are eligible through an employer, health plan or care provider. Its four programs cover Diabetes Management, a Diabetes Prevention Program, Hypertension Management and Weight Management, and members may enroll in one or several programs for which they qualify. Eligibility for Diabetes Management requires a type 1 or type 2 diabetes diagnosis; Hypertension Management requires high blood pressure.

Each program combines connected health-monitoring devices with human support. Depending on the enrolled condition(s), members may receive a cellular-connected blood glucose meter with unlimited test strips and lancets shipped to their home, a blood pressure monitor that records readings into the mobile app, and/or a connected scale. Members work on an ongoing basis with the same certified health coach, who addresses diet, exercise, medication, motivation, nutrition and mental health, and have access to physicians and mental health specialists. The company monitors readings around the clock and contacts members directly when dangerous glucose levels are detected. Program content is based on clinical standards of care including guidance from the American Diabetes Association, American Heart Association and Centers for Disease Control and Prevention, and coaching support is also offered in Spanish.

Livongo care providers can prescribe GLP-1 medications, when clinically appropriate, to members enrolled in condition care, alongside lifestyle-modification guidance and support from nutritionists, coaches and other licensed professionals. GLP-1 availability depends on the specific benefit offering purchased by the member's employer, health plan or care provider.

Business model

Programs are sold to employers, health plans and healthcare providers, which pay for the service on behalf of eligible members; enrolled members pay nothing, including shipping of devices and supplies.

Sponsor-paid: the member's employer, health plan or healthcare provider funds the condition management program, with no additional cost or shipping charges to the member.

Traction

The company states it has helped more than 730,000 patients. Reported program outcomes include a 48% reduced incidence of diabetes over a three-year period, an average systolic blood pressure reduction of 15 mmHg, and 46% of patients losing 5% or more of their starting weight. Member testimonials and Trustpilot reviews are featured on the site.

Latest developments

The current program includes GLP-1 medication access for enrolled condition management members where the sponsor's benefit offering supports it, paired with lifestyle-modification coaching. The website also carries a notice regarding devices.

Full profile — market position, technology, go-to-market, geography

Market position

Operates as a Teladoc Health-branded chronic care management offering within the employer and health plan benefits channel.

Bundles unlimited testing supplies and unlimited coaching access, a single dedicated certified coach for continuity, 24/7 monitoring with proactive outreach, Spanish-language support, and access to physicians, mental health specialists and clinically appropriate GLP-1 prescribing within one program.

Technology

Connected devices (a blood glucose meter that automatically uploads readings, a blood pressure monitor, a connected scale) feed a mobile app that provides real-time insights, personalized tips, activity tracking, progress views and multi-period summaries of glucose logs (10, 14, 30 and 90 days) that members can share with their doctors. A monitoring layer flags dangerous glucose readings for outreach 24/7.

Go-to-market

Distribution runs through benefit sponsors. Prospective members check eligibility on the Livongo website or app, then receive a welcome kit, connected device(s) and access to coaching upon enrollment.

Employers, health plans and care providers as buyers; end users are adults diagnosed with type 1 or type 2 diabetes, prediabetes risk, hypertension, or seeking weight management, who are eligible through their sponsor.

Geography

Headquartered in Mountain View, United States, serving members in the U.S. through employer and health plan benefits, with English- and Spanish-language support.

Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Average systolic blood pressure reductionJan 202515 mmHg
HeadcountAug 202680
Patients helped (cumulative)Jan 2025730,000 patients
Reduced incidence of diabetes over three yearsJan 202548%
Share of patients losing 5% or more of starting weightJan 202546%

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Founder mafia

5 people who came through Livongo went on to found or lead other companies.

Legal entities · 1

corporate structure
LivongoDelaware

In the news

Research sources · 1

primary sources listed

1 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Livongo do?
Livongo, part of Teladoc Health, provides employer- and health-plan-sponsored chronic condition management programs.
Who are Livongo's investors?
Livongo's investors include 7wire Ventures, Corewell Health Ventures, General Catalyst, Human Capital, Kleiner Perkins, Sapphire Ventures, Slow Ventures, Threshold Ventures and 3 more.
How much funding has Livongo raised?
Livongo has disclosed $227M raised across 4 rounds.
Where is Livongo headquartered?
Livongo is headquartered in Mountain View, US.